世界の固形腫瘍治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Solid Tumor Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z5375
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、92ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、固形腫瘍治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、ホルモン療法、免疫療法、標的療法）、用途別市場規模（乳がん、肺がん、結腸直腸がん、前立腺がん、子宮頸がん、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・固形腫瘍治療薬の市場動向
・企業の競争状況、市場シェア
・固形腫瘍治療薬の種類別市場規模（化学療法、ホルモン療法、免疫療法、標的療法）
・固形腫瘍治療薬の用途別市場規模（乳がん、肺がん、結腸直腸がん、前立腺がん、子宮頸がん、その他）
・固形腫瘍治療薬の北米市場規模2016-2027（アメリカ、カナダ）
・固形腫瘍治療薬のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・固形腫瘍治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・固形腫瘍治療薬の中南米市場規模2016-2027（メキシコ、ブラジル）
・固形腫瘍治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Hoffmann-La Roche、Johnson & Johnson、Novartis、AstraZeneca、Biogen Idec、Boehringer Ingelheim、GlaxoSmithKline、Eli Lilly、Kyowa Hakko Kirin、Abbott Laboratories、Baxter International）
・結論

In cancer, solid tumors are formed by aggregation of abnormal tissues that do not comprise of any liquid or cyst.
Increasing incidences of solid tumor among cancer patients and growing prevalence of various types of metastatic cancers are the major factors that are expected to drive the growth of the global solid tumor therapeutics market.

Market Analysis and Insights: Global Solid Tumor Therapeutics Market
The global Solid Tumor Therapeutics market size is projected to reach US$ 198590 million by 2026, from US$ 111440 million in 2019, at a CAGR of 8.5% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Solid Tumor Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Solid Tumor Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Solid Tumor Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Solid Tumor Therapeutics market.

Global Solid Tumor Therapeutics Scope and Market Size
Solid Tumor Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Solid Tumor Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Chemotherapy
Hormone Therapy
Immunotherapy
Targeted Therapy

Segment by Application
Breast Cancer
Lung Cancer
Colorectal Cancer
Prostate Cancer
Cervical Cancer
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Hoffmann-La Roche
Johnson & Johnson
Novartis
AstraZeneca
Biogen Idec
Boehringer Ingelheim
GlaxoSmithKline
Eli Lilly
Kyowa Hakko Kirin

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Solid Tumor Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Chemotherapy
1.2.3 Hormone Therapy
1.2.4 Immunotherapy
1.2.5 Targeted Therapy
1.3 Market by Application
1.3.1 Global Solid Tumor Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Breast Cancer
1.3.3 Lung Cancer
1.3.4 Colorectal Cancer
1.3.5 Prostate Cancer
1.3.6 Cervical Cancer
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Solid Tumor Therapeutics Market Perspective (2016-2027)
2.2 Solid Tumor Therapeutics Growth Trends by Regions
2.2.1 Solid Tumor Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Solid Tumor Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Solid Tumor Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Solid Tumor Therapeutics Industry Dynamic
2.3.1 Solid Tumor Therapeutics Market Trends
2.3.2 Solid Tumor Therapeutics Market Drivers
2.3.3 Solid Tumor Therapeutics Market Challenges
2.3.4 Solid Tumor Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Solid Tumor Therapeutics Players by Revenue
3.1.1 Global Top Solid Tumor Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Solid Tumor Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Solid Tumor Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Solid Tumor Therapeutics Revenue
3.4 Global Solid Tumor Therapeutics Market Concentration Ratio
3.4.1 Global Solid Tumor Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Solid Tumor Therapeutics Revenue in 2020
3.5 Solid Tumor Therapeutics Key Players Head office and Area Served
3.6 Key Players Solid Tumor Therapeutics Product Solution and Service
3.7 Date of Enter into Solid Tumor Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Solid Tumor Therapeutics Breakdown Data by Type
4.1 Global Solid Tumor Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Solid Tumor Therapeutics Forecasted Market Size by Type (2022-2027)

5 Solid Tumor Therapeutics Breakdown Data by Application
5.1 Global Solid Tumor Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Solid Tumor Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Solid Tumor Therapeutics Market Size (2016-2027)
6.2 North America Solid Tumor Therapeutics Market Size by Type
6.2.1 North America Solid Tumor Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Solid Tumor Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Solid Tumor Therapeutics Market Size by Type (2016-2027)
6.3 North America Solid Tumor Therapeutics Market Size by Application
6.3.1 North America Solid Tumor Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Solid Tumor Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Solid Tumor Therapeutics Market Size by Application (2016-2027)
6.4 North America Solid Tumor Therapeutics Market Size by Country
6.4.1 North America Solid Tumor Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Solid Tumor Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Solid Tumor Therapeutics Market Size (2016-2027)
7.2 Europe Solid Tumor Therapeutics Market Size by Type
7.2.1 Europe Solid Tumor Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Solid Tumor Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Solid Tumor Therapeutics Market Size by Type (2016-2027)
7.3 Europe Solid Tumor Therapeutics Market Size by Application
7.3.1 Europe Solid Tumor Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Solid Tumor Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Solid Tumor Therapeutics Market Size by Application (2016-2027)
7.4 Europe Solid Tumor Therapeutics Market Size by Country
7.4.1 Europe Solid Tumor Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Solid Tumor Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Solid Tumor Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Solid Tumor Therapeutics Market Size by Type
8.2.1 Asia-Pacific Solid Tumor Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Solid Tumor Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Solid Tumor Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Solid Tumor Therapeutics Market Size by Application
8.3.1 Asia-Pacific Solid Tumor Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Solid Tumor Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Solid Tumor Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Solid Tumor Therapeutics Market Size by Region
8.4.1 Asia-Pacific Solid Tumor Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Solid Tumor Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Solid Tumor Therapeutics Market Size (2016-2027)
9.2 Latin America Solid Tumor Therapeutics Market Size by Type
9.2.1 Latin America Solid Tumor Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Solid Tumor Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Solid Tumor Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Solid Tumor Therapeutics Market Size by Application
9.3.1 Latin America Solid Tumor Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Solid Tumor Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Solid Tumor Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Solid Tumor Therapeutics Market Size by Country
9.4.1 Latin America Solid Tumor Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Solid Tumor Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Solid Tumor Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Solid Tumor Therapeutics Market Size by Type
10.2.1 Middle East & Africa Solid Tumor Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Solid Tumor Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Solid Tumor Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Solid Tumor Therapeutics Market Size by Application
10.3.1 Middle East & Africa Solid Tumor Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Solid Tumor Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Solid Tumor Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Solid Tumor Therapeutics Market Size by Country
10.4.1 Middle East & Africa Solid Tumor Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Solid Tumor Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Hoffmann-La Roche
11.1.1 Hoffmann-La Roche Company Details
11.1.2 Hoffmann-La Roche Business Overview
11.1.3 Hoffmann-La Roche Solid Tumor Therapeutics Introduction
11.1.4 Hoffmann-La Roche Revenue in Solid Tumor Therapeutics Business (2016-2021)
11.1.5 Hoffmann-La Roche Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Details
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Solid Tumor Therapeutics Introduction
11.2.4 Johnson & Johnson Revenue in Solid Tumor Therapeutics Business (2016-2021)
11.2.5 Johnson & Johnson Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Solid Tumor Therapeutics Introduction
11.3.4 Novartis Revenue in Solid Tumor Therapeutics Business (2016-2021)
11.3.5 Novartis Recent Development
11.4 AstraZeneca
11.4.1 AstraZeneca Company Details
11.4.2 AstraZeneca Business Overview
11.4.3 AstraZeneca Solid Tumor Therapeutics Introduction
11.4.4 AstraZeneca Revenue in Solid Tumor Therapeutics Business (2016-2021)
11.4.5 AstraZeneca Recent Development
11.5 Biogen Idec
11.5.1 Biogen Idec Company Details
11.5.2 Biogen Idec Business Overview
11.5.3 Biogen Idec Solid Tumor Therapeutics Introduction
11.5.4 Biogen Idec Revenue in Solid Tumor Therapeutics Business (2016-2021)
11.5.5 Biogen Idec Recent Development
11.6 Boehringer Ingelheim
11.6.1 Boehringer Ingelheim Company Details
11.6.2 Boehringer Ingelheim Business Overview
11.6.3 Boehringer Ingelheim Solid Tumor Therapeutics Introduction
11.6.4 Boehringer Ingelheim Revenue in Solid Tumor Therapeutics Business (2016-2021)
11.6.5 Boehringer Ingelheim Recent Development
11.7 GlaxoSmithKline
11.7.1 GlaxoSmithKline Company Details
11.7.2 GlaxoSmithKline Business Overview
11.7.3 GlaxoSmithKline Solid Tumor Therapeutics Introduction
11.7.4 GlaxoSmithKline Revenue in Solid Tumor Therapeutics Business (2016-2021)
11.7.5 GlaxoSmithKline Recent Development
11.8 Eli Lilly
11.8.1 Eli Lilly Company Details
11.8.2 Eli Lilly Business Overview
11.8.3 Eli Lilly Solid Tumor Therapeutics Introduction
11.8.4 Eli Lilly Revenue in Solid Tumor Therapeutics Business (2016-2021)
11.8.5 Eli Lilly Recent Development
11.9 Kyowa Hakko Kirin
11.9.1 Kyowa Hakko Kirin Company Details
11.9.2 Kyowa Hakko Kirin Business Overview
11.9.3 Kyowa Hakko Kirin Solid Tumor Therapeutics Introduction
11.9.4 Kyowa Hakko Kirin Revenue in Solid Tumor Therapeutics Business (2016-2021)
11.9.5 Kyowa Hakko Kirin Recent Development
11.10 Abbott Laboratories
11.10.1 Abbott Laboratories Company Details
11.10.2 Abbott Laboratories Business Overview
11.10.3 Abbott Laboratories Solid Tumor Therapeutics Introduction
11.10.4 Abbott Laboratories Revenue in Solid Tumor Therapeutics Business (2016-2021)
11.10.5 Abbott Laboratories Recent Development
11.11 Baxter International
11.11.1 Baxter International Company Details
11.11.2 Baxter International Business Overview
11.11.3 Baxter International Solid Tumor Therapeutics Introduction
11.11.4 Baxter International Revenue in Solid Tumor Therapeutics Business (2016-2021)
11.11.5 Baxter International Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Solid Tumor Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Chemotherapy
Table 3. Key Players of Hormone Therapy
Table 4. Key Players of Immunotherapy
Table 5. Key Players of Targeted Therapy
Table 6. Global Solid Tumor Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Solid Tumor Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Solid Tumor Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Solid Tumor Therapeutics Market Share by Regions (2016-2021)
Table 10. Global Solid Tumor Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Solid Tumor Therapeutics Market Share by Regions (2022-2027)
Table 12. Solid Tumor Therapeutics Market Trends
Table 13. Solid Tumor Therapeutics Market Drivers
Table 14. Solid Tumor Therapeutics Market Challenges
Table 15. Solid Tumor Therapeutics Market Restraints
Table 16. Global Solid Tumor Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Solid Tumor Therapeutics Market Share by Players (2016-2021)
Table 18. Global Top Solid Tumor Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Solid Tumor Therapeutics as of 2020)
Table 19. Ranking of Global Top Solid Tumor Therapeutics Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Solid Tumor Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Solid Tumor Therapeutics Product Solution and Service
Table 23. Date of Enter into Solid Tumor Therapeutics Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Solid Tumor Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Solid Tumor Therapeutics Revenue Market Share by Type (2016-2021)
Table 27. Global Solid Tumor Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Solid Tumor Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Solid Tumor Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Solid Tumor Therapeutics Revenue Market Share by Application (2016-2021)
Table 31. Global Solid Tumor Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Solid Tumor Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Solid Tumor Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Solid Tumor Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Solid Tumor Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Solid Tumor Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Solid Tumor Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Solid Tumor Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Solid Tumor Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Solid Tumor Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Solid Tumor Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Solid Tumor Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Solid Tumor Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Solid Tumor Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Solid Tumor Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Solid Tumor Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Solid Tumor Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Solid Tumor Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Solid Tumor Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Solid Tumor Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Solid Tumor Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Solid Tumor Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Solid Tumor Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Solid Tumor Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Solid Tumor Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Solid Tumor Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Solid Tumor Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Solid Tumor Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Solid Tumor Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Solid Tumor Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Solid Tumor Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Solid Tumor Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 63. Hoffmann-La Roche Company Details
Table 64. Hoffmann-La Roche Business Overview
Table 65. Hoffmann-La Roche Solid Tumor Therapeutics Product
Table 66. Hoffmann-La Roche Revenue in Solid Tumor Therapeutics Business (2016-2021) & (US$ Million)
Table 67. Hoffmann-La Roche Recent Development
Table 68. Johnson & Johnson Company Details
Table 69. Johnson & Johnson Business Overview
Table 70. Johnson & Johnson Solid Tumor Therapeutics Product
Table 71. Johnson & Johnson Revenue in Solid Tumor Therapeutics Business (2016-2021) & (US$ Million)
Table 72. Johnson & Johnson Recent Development
Table 73. Novartis Company Details
Table 74. Novartis Business Overview
Table 75. Novartis Solid Tumor Therapeutics Product
Table 76. Novartis Revenue in Solid Tumor Therapeutics Business (2016-2021) & (US$ Million)
Table 77. Novartis Recent Development
Table 78. AstraZeneca Company Details
Table 79. AstraZeneca Business Overview
Table 80. AstraZeneca Solid Tumor Therapeutics Product
Table 81. AstraZeneca Revenue in Solid Tumor Therapeutics Business (2016-2021) & (US$ Million)
Table 82. AstraZeneca Recent Development
Table 83. Biogen Idec Company Details
Table 84. Biogen Idec Business Overview
Table 85. Biogen Idec Solid Tumor Therapeutics Product
Table 86. Biogen Idec Revenue in Solid Tumor Therapeutics Business (2016-2021) & (US$ Million)
Table 87. Biogen Idec Recent Development
Table 88. Boehringer Ingelheim Company Details
Table 89. Boehringer Ingelheim Business Overview
Table 90. Boehringer Ingelheim Solid Tumor Therapeutics Product
Table 91. Boehringer Ingelheim Revenue in Solid Tumor Therapeutics Business (2016-2021) & (US$ Million)
Table 92. Boehringer Ingelheim Recent Development
Table 93. GlaxoSmithKline Company Details
Table 94. GlaxoSmithKline Business Overview
Table 95. GlaxoSmithKline Solid Tumor Therapeutics Product
Table 96. GlaxoSmithKline Revenue in Solid Tumor Therapeutics Business (2016-2021) & (US$ Million)
Table 97. GlaxoSmithKline Recent Development
Table 98. Eli Lilly Company Details
Table 99. Eli Lilly Business Overview
Table 100. Eli Lilly Revenue in Solid Tumor Therapeutics Business (2016-2021) & (US$ Million)
Table 101. Eli Lilly Recent Development
Table 102. Kyowa Hakko Kirin Company Details
Table 103. Kyowa Hakko Kirin Business Overview
Table 104. Kyowa Hakko Kirin Solid Tumor Therapeutics Product
Table 105. Kyowa Hakko Kirin Revenue in Solid Tumor Therapeutics Business (2016-2021) & (US$ Million)
Table 106. Kyowa Hakko Kirin Recent Development
Table 107. Abbott Laboratories Company Details
Table 108. Abbott Laboratories Business Overview
Table 109. Abbott Laboratories Solid Tumor Therapeutics Product
Table 110. Abbott Laboratories Revenue in Solid Tumor Therapeutics Business (2016-2021) & (US$ Million)
Table 111. Abbott Laboratories Recent Development
Table 112. Baxter International Company Details
Table 113. Baxter International Business Overview
Table 114. Baxter International Solid Tumor Therapeutics Product
Table 115. Baxter International Revenue in Solid Tumor Therapeutics Business (2016-2021) & (US$ Million)
Table 116. Baxter International Recent Development
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Solid Tumor Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Chemotherapy Features
Figure 3. Hormone Therapy Features
Figure 4. Immunotherapy Features
Figure 5. Targeted Therapy Features
Figure 6. Global Solid Tumor Therapeutics Market Share by Application: 2020 VS 2027
Figure 7. Breast Cancer Case Studies
Figure 8. Lung Cancer Case Studies
Figure 9. Colorectal Cancer Case Studies
Figure 10. Prostate Cancer Case Studies
Figure 11. Cervical Cancer Case Studies
Figure 12. Others Case Studies
Figure 13. Solid Tumor Therapeutics Report Years Considered
Figure 14. Global Solid Tumor Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 15. Global Solid Tumor Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Solid Tumor Therapeutics Market Share by Regions: 2020 VS 2027
Figure 17. Global Solid Tumor Therapeutics Market Share by Regions (2022-2027)
Figure 18. Global Solid Tumor Therapeutics Market Share by Players in 2020
Figure 19. Global Top Solid Tumor Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Solid Tumor Therapeutics as of 2020
Figure 20. The Top 10 and 5 Players Market Share by Solid Tumor Therapeutics Revenue in 2020
Figure 21. Global Solid Tumor Therapeutics Revenue Market Share by Type (2016-2021)
Figure 22. Global Solid Tumor Therapeutics Revenue Market Share by Type (2022-2027)
Figure 23. North America Solid Tumor Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. North America Solid Tumor Therapeutics Market Share by Type (2016-2027)
Figure 25. North America Solid Tumor Therapeutics Market Share by Application (2016-2027)
Figure 26. North America Solid Tumor Therapeutics Market Share by Country (2016-2027)
Figure 27. United States Solid Tumor Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Canada Solid Tumor Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Solid Tumor Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Solid Tumor Therapeutics Market Share by Type (2016-2027)
Figure 31. Europe Solid Tumor Therapeutics Market Share by Application (2016-2027)
Figure 32. Europe Solid Tumor Therapeutics Market Share by Country (2016-2027)
Figure 33. Germany Solid Tumor Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. France Solid Tumor Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. U.K. Solid Tumor Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Italy Solid Tumor Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Russia Solid Tumor Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Nordic Solid Tumor Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Solid Tumor Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Solid Tumor Therapeutics Market Share by Type (2016-2027)
Figure 41. Asia-Pacific Solid Tumor Therapeutics Market Share by Application (2016-2027)
Figure 42. Asia-Pacific Solid Tumor Therapeutics Market Share by Region (2016-2027)
Figure 43. China Solid Tumor Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Japan Solid Tumor Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. South Korea Solid Tumor Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Southeast Asia Solid Tumor Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. India Solid Tumor Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Australia Solid Tumor Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Solid Tumor Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Solid Tumor Therapeutics Market Share by Type (2016-2027)
Figure 51. Latin America Solid Tumor Therapeutics Market Share by Application (2016-2027)
Figure 52. Latin America Solid Tumor Therapeutics Market Share by Country (2016-2027)
Figure 53. Mexico Solid Tumor Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Brazil Solid Tumor Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Solid Tumor Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Solid Tumor Therapeutics Market Share by Type (2016-2027)
Figure 57. Middle East & Africa Solid Tumor Therapeutics Market Share by Application (2016-2027)
Figure 58. Middle East & Africa Solid Tumor Therapeutics Market Share by Country (2016-2027)
Figure 59. Turkey Solid Tumor Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Saudi Arabia Solid Tumor Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. UAE Solid Tumor Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Hoffmann-La Roche Revenue Growth Rate in Solid Tumor Therapeutics Business (2016-2021)
Figure 63. Johnson & Johnson Revenue Growth Rate in Solid Tumor Therapeutics Business (2016-2021)
Figure 64. Novartis Revenue Growth Rate in Solid Tumor Therapeutics Business (2016-2021)
Figure 65. AstraZeneca Revenue Growth Rate in Solid Tumor Therapeutics Business (2016-2021)
Figure 66. Biogen Idec Revenue Growth Rate in Solid Tumor Therapeutics Business (2016-2021)
Figure 67. Boehringer Ingelheim Revenue Growth Rate in Solid Tumor Therapeutics Business (2016-2021)
Figure 68. GlaxoSmithKline Revenue Growth Rate in Solid Tumor Therapeutics Business (2016-2021)
Figure 69. Eli Lilly Revenue Growth Rate in Solid Tumor Therapeutics Business (2016-2021)
Figure 70. Kyowa Hakko Kirin Revenue Growth Rate in Solid Tumor Therapeutics Business (2016-2021)
Figure 71. Abbott Laboratories Revenue Growth Rate in Solid Tumor Therapeutics Business (2016-2021)
Figure 72. Baxter International Revenue Growth Rate in Solid Tumor Therapeutics Business (2016-2021)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed

以下、関連資料のご紹介

世界の固形腫瘍治療薬市場規模・現状・予測（2021年-2027年）

Global Solid Tumor Therapeutics Market Size, Status and Forecast 2021-2027
QYR2104Z5375 2021年4月 92Pages
QYResearch社発行の本調査資料では、固形腫瘍治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、ホルモン療法、免疫療法、標的療法）、用途別市場規模（乳がん、肺がん、結腸直腸がん、前立腺がん、子宮頸がん、その他）、主要地域別市...

世界の固形腫瘍治療薬市場規模・現状・予測（2021年-2027年）

Global Solid Tumors Drugs Market Size, Status and Forecast 2021-2027
QYR2104Z5376 2021年4月 125Pages
QYResearch社発行の本調査資料では、固形腫瘍治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（小分子、生物製剤）、用途別市場規模（病院、診療所、学術研究所）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、...

世界の固形腫瘍治療薬市場規模・現状・予測（2021年-2027年）

Global Drugs for Solid Tumors Market Size, Status and Forecast 2021-2027
QYR2104Z2004 2021年4月 131Pages
QYResearch社発行の本調査資料では、固形腫瘍治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（小分子、生物製剤）、用途別市場規模（病院、診療所、学術・研究所）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国...

世界の固形腫瘍検査市場規模・現状・予測（2021年-2027年）

Global Solid Tumor Testing Market Size, Status and Forecast 2021-2027
QYR2104Z5374 2021年4月 90Pages
QYResearch社発行の本調査資料では、固形腫瘍検査のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（従来検査、非従来検査）、用途別市場規模（病院、診断研究所、学術研究所）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、...

世界の固形腫瘍検査市場規模・現状・予測（2021年-2027年）

世界の脳腫瘍治療市場規模・現状・予測（2021年-2027年）

Global Brain Tumor Therapeutics Market Size, Status and Forecast 2021-2027
QYR2104Z0980 2021年4月 90Pages
QYResearch社発行の本調査資料では、脳腫瘍治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（手術、放射線療法、標的療法、化学療法、免疫療法）、用途別市場規模（病院、腫瘍治療センター、その他）、主要地域別市場規模（北米、アメリカ、ヨーロ...

世界の脳腫瘍診断・治療市場規模・現状・予測（2021年-2027年）

Global Brain Tumor Diagnosis and Therapeutics Market Size, Status and Forecast 2021-2027
QYR2104Z0978 2021年4月 98Pages
QYResearch社発行の本調査資料では、脳腫瘍診断・治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（MRI、CTスキャン、組織サンプリング、PET-CTスキャン、脳動脈造影、腰椎穿刺、分子検査、EEG）、用途別市場規模（手術、放射線療法...

世界の腫瘍免疫療法市場規模・現状・予測（2021年-2027年）

Global Tumor Immunotherapy Market Size, Status and Forecast 2021-2027
QYR2104Z5757 2021年4月 127Pages
QYResearch社発行の本調査資料では、腫瘍免疫療法のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（腫瘍浸潤リンパ球（TIL）治療、操作T細胞受容体（TCR）療法、キメラ抗原受容体（CAR）T細胞療法、ナチュラルキラー（NK）細胞療法、その...

世界の腫瘍免疫療法市場規模・現状・予測（2021年-2027年）

世界の固形腫瘍治療薬市場規模・現状・予測（2021年-2027年） In cancer, solid tumors are formed by aggregation of abnormal tissues that do not comprise of any liquid or cyst. Increasing incidences of solid tumor among cancer patients and growing prevalence of various types of metastatic cancers are the major factors that are expected to drive the growth of th…
世界の小分子標的がん治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Small Molecule Targeted Cancer Therapy Market The global Small Molecule Targeted Cancer Therapy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis a…
世界の卵巣がん遺伝子治療市場規模・現状・予測（2021年-2027年） Ovarian cancer occurs and arises from several types of cells within the ovary, and it has the lowest survival rate of all gynecological cancers. Among many types, epithelial ovarian cancer (EOC) is the most common ovarian cancer, whereas ovarian low malignant potential tumor (OLMPT), germ cell tumor…
世界の結腸直腸がん診断・治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Colorectal Cancer Diagnosis and Therapeutics Market The global Colorectal Cancer Diagnosis and Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy i…
世界の結腸直腸がん診断・治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Colorectal Cancer Diagnosis and Therapeutics Market The global Colorectal Cancer Diagnosis and Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy i…